17.05.2017 Views

Thrombectomy Devices

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Thrombectomy</strong><br />

<strong>Devices</strong> Market<br />

Opportunities and Forecasts,<br />

2014 – 2021


<strong>Thrombectomy</strong> <strong>Devices</strong> Market: Future & Growth<br />

• <strong>Thrombectomy</strong> Market was valued at $982 million in 2016, and<br />

is expected to reach $1,389 million by 2022<br />

• Supported by a CAGR of 5.9% during the forecast period 2014 -<br />

2022<br />

• Mechanical thrombectomy would continue to be the preferred<br />

technology throughout analysis period.<br />

• North America dominated with around half of the market share<br />

in 2015


<strong>Thrombectomy</strong> <strong>Devices</strong> Market: Factors for<br />

Market Growth<br />

• High occurrences of acute myocardial infarction, peripheral artery disease,<br />

deep vein thrombosis, VTE (venous thromboembolism) and pulmonary<br />

embolism owing to the sedentary, and unhealthy lifestyle<br />

• The upcoming trend which involves the combination of decompressive<br />

hemicraniectomy and endovascular thrombectomy to treat patients with<br />

cerebral venous thrombosis.<br />

• Better healthcare infrastructure and increase in demand for minimallyinvasive<br />

treatments<br />

• Rise in the geriatric population, which increases incidence of cardiovascular<br />

diseases<br />

• Technological advancements & innovations


<strong>Thrombectomy</strong> <strong>Devices</strong> Market: Key Factors<br />

• Mechanical thrombectomy devices was the leading segment in<br />

2015, and is expected to maintain this position throughout the<br />

analysis period.<br />

• Neurovascular disorder is the major indication which uses<br />

thrombectomy devices for treatment; with over half of the total<br />

market share in 2015.<br />

• Peripheral and coronary diseases segments are projected to grow<br />

at a significant CAGR.<br />

• Reusable thrombectomy devices is projected to grow at a CAGR of<br />

7.7%.<br />

• U.S market for thrombectomy devices is projected to grow at a<br />

CAGR of 5.0%.<br />

• U.S. was the largest country market in 2015, and is projected to<br />

maintain its lead until 2022.


<strong>Thrombectomy</strong> <strong>Devices</strong> Market Segmentation<br />

Market is segmented into various forms:<br />

By Technology<br />

By Type<br />

By Utility<br />

By Diseases<br />

• Mechanical<br />

<strong>Thrombectomy</strong><br />

<strong>Devices</strong><br />

• Aspiration<br />

<strong>Thrombectomy</strong><br />

<strong>Devices</strong><br />

• Rheolytic<br />

<strong>Thrombectomy</strong><br />

<strong>Devices</strong><br />

• Automated<br />

<strong>Devices</strong><br />

• Manual<br />

<strong>Devices</strong><br />

• Reusable<br />

<strong>Devices</strong><br />

• Disposable<br />

<strong>Devices</strong><br />

• Peripheral<br />

Diseases<br />

• Coronary<br />

Diseases<br />

• Neural<br />

Diseases


<strong>Thrombectomy</strong> <strong>Devices</strong> Market Segmentation<br />

• Geographically, North America occupied a major market share in<br />

2015, and is expected to continue leading during analysis<br />

period. This was attributed to the sedentary and unhealthy<br />

lifestyle of the current generation, demand of better healthcare<br />

infrastructure, and increase in demand for minimally-invasive<br />

treatments and incidence of cardiovascular diseases.<br />

• Asia-Pacific followed by LAMEA are expected to be the fastest<br />

growing regions, owing to the presence of ample growth<br />

opportunities in terms of unmet medical needs for the<br />

treatment of thrombus.


<strong>Thrombectomy</strong> <strong>Devices</strong> Market: Key Players<br />

• Boston Scientific Corporation<br />

• Medtronic Plc<br />

• Teleflex Incorporated<br />

• Penumbra Inc.<br />

• The Spectranetics Corporation<br />

• AngioDynamics, Inc.<br />

• Terumo Corporation<br />

• Johnson and Johnson, Inc.<br />

• Stryker Corporation, and<br />

• Vascular Solutions, Inc.


Summary:<br />

This is due to the fact that the disposable devices reduce the chances of contamination<br />

and severity of in-hospitalization diseases. However, the reusable thrombectomy devices<br />

will gain grounds in the near future and will grow faster as compared to disposable<br />

thrombectomy devices owing to the advancements in the technology during the forecast<br />

period. Reusable thrombectomy devices are engineered to improve the efficiency by<br />

limiting the disposable costs and biological wastage generation.<br />

To know more about <strong>Thrombectomy</strong> <strong>Devices</strong> Market, visit:<br />

https://www.alliedmarketresearch.com/thrombectomy-devices-market<br />

Follow us on:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!